The Secretome Engages STAT3 to Favor a Cytokine-Rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0179
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Stat3 Contributes to Resistance Toward BCR-ABL Inhibitors in a Bone Marrow Microenvironment Model of Drug Resistance

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

The Tumor Microenvironment Underlies Acquired Resistance to CSF-1R Inhibition in Gliomas

Science
MultidisciplinaryPhilosophy of ScienceHistory
2016English

Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2016English

A Dynamic N6-Methyladenosine Methylome Regulates Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors

Cell Research
Cell BiologyMolecular Biology
2018English

Niclosamide Overcomes Acquired Resistance to Erlotinib Through Suppression of STAT3 in Non-Small Cell Lung Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Cutting Edge: Inherent and Acquired Resistance to Radiation-Induced Apoptosis in B Cells: A Pivotal Role for STAT3

Journal of Immunology
AllergyImmunology
2006English

P2.13-37 Chloroquine Overcomes Acquired Resistance to Icotinib in Vitro and in Vivo Through STAT3/STMN1 Pathway

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy